Articles, Whitepapers, Videos, Publications.


Please feel free to browse a our library of resources regarding innovations in Patient Adherence.


PerformRx Launches Personalized Digital Mobile Platform to Improve Medication Adherence for Asthma Patients



FOR IMMEDIATE RELEASE                                                                                                                  Contact: Michelle Davidson

February 24, 2015                                                                                                                                     215-208-9816



PerformRx Launches Personalized Digital Mobile Platform to Improve

Medication Adherence for Asthma Patients


HealthNHand helps health plans extend care management with

air quality and behavior change interventions


Philadelphia, PA – PerformRx, (www.performrx.com), a URAC-accredited, full service pharmacy benefits manager with industry-leading clinical programs, announced today the launch of HealthNHand, a personalized digital mobile platform aimed at improving medication adherence. HealthNHand will be initially offered to members of AmeriHealth District of Columbia, the largest Medicaid managed care organization in the District.


HealthNHand, developed by MEMOTEXT, a health care technology company, is designed to improve adherence to treatment regimens. Participants receive reminders to take their asthma medications and complete questionnaires about their health status via interactive voice response, short message service (SMS) or email. HealthNHand’s personalized information, targeted support and daily air quality forecasts, generated for each user based on results from the questionnaires, help asthma patients become more aware and engaged in their own self-care.



How One Healthcare Entrepreneur Created His Own Access

Christina Hernandez Sherwood on May 20, 2014.

Like many healthcare entrepreneurs, Amos Adler of MEMOTEXT found it difficult to access the stakeholders who could help to make his patient adherence company a success. The challenge, he said, is that access is dependent on how a startup can align with the business model of the stakeholders involved. “Can you get into their business model,” he said, “and can you get into the clinical workflow?”

To get around that, Adler and MEMOTEXT have found their own solution. “We’re in the midst of building out what we call ‘the alliance for adherence,'” he said. The alliance, Adler said, consists of a group of stakeholders who have access to patients and a common interest in patient adherence.

Here are other entrepreneurial insights from Adler:


“Everyone is Different and People Change. Our Technology Should Know as Much and Adapt with us. MEMOTEXT Personalizes your Health Interaction Experience.”

Dec 19th, 2012. By Amos Adler

Prior to founding MEMOTEXT, Amos Adler was a business solutions architect for the Bell Canada Enterprises (BCE) group of Companies. While at Bell Canada, Bell Mobility and other operating entities, he managed the design, implementation and integration of various CRM, ERP, Voice/Speech Recognition, IVR and web 2.0 and CTI – legacy system integration initiatives.

MEMOTEXT is a professional services firm and SaaS engine that focusses solely on medication and treatment compliance programs for healthcare stakeholders. MEMOTEXT® specializes in evidence based personalization of patient compliance interventions.

With a proprietary methodology and The MEMOTEXT Personologic™ inference engine, we integrate behavior modification, education and real-time support into the everyday lives of patients using everyday technologies patients already have. Our ability to learn and remember previously reported knowledge, intentions and behaviors allows us to adapt communications to changing attitudes, knowledge levels and circumstances of each patient using best of breed, secure mobile, speech and social medication adherence tools.


Smith & Nephew and MEMOTEXT Launch the EXOGEN° Connects Fracture Treatment Adherence Program

Smith & Nephew and MEMOTEXT Launch the EXOGEN° Connects Fracture Treatment Adherence Program

Johns Hopkins Patient Adherence Study with MEMOTEXT

Johns Hopkins study demonstrates 16% increase in patient adherence using MEMOTEXT and Microsoft HealthVault in the first randomized clinical trial of its kind in North America.

2009: Patient Compliance

8th Annual CBI Patient Compliance Adherence & Persistency Summit

MEMOTEXT Johns Hopkins Collaboration

MEMOTEXT® Collaborating with Johns Hopkins University & Microsoft HealthVault

MEMOTEXT Improving Type 2 Diabetes – Text

Improving the treatment of Type II Diabetes one Reminder at a time.

Patient Adherence as a Strategic Priority

Ensure Adherence Remains a Strategic Priority

MEMOTEXT & Biogen Idec Canada Announce Groundbreaking Partnership

MEMOTEXT & Biogen Idec Canada Announce Groundbreaking Partnership to help patients with MS

Social Support and Patient Adherence

Social Support and Patient Adherence

How social relationships influence medication compliance
This week’s focus is on social support – an area that has received extensive attention in health research.  Social support is what arises from our social relationships; it is the care and assistance we receive from others, especially as it relates to physical and mental health.  With such a broad definition, social support has been shown to affect nearly every health outcome studied.  There are differences in the extent of that impact, however, depending on the specific health issue or behavior, how social support is defined and measured, and factors related to the individuals involved.  As an introduction to this topic, we’ll focus on the different types of social support and the factors that most commonly determine how helpful it is in managing health and its effect on patient adherence.

Social support encompasses a range of behaviors and these are often categorized as:  i) emotional support, ii) instrumental (or practical) support, iii) informational support, and iv) appraisal.  Emotional support includes care, empathy, companionship, and trust whileinstrumental support includes tangible or practical aid (such as providing money or transportation to a doctor’s appointment for example).  Informational support includes advice, suggestions and other forms of education/knowledge about health while appraisal provides feedback and affirmation that can be used for self-evaluation of health behaviors and/or beliefs.  A single source of social support may provide multiple kinds of social support (e.g., a friend who listens to your struggles with healthy eating and recommends a good cookbook) or only one kind of social support (e.g., a pharmacist who tells you how to properly take your medications).

In health research social support is often measured as perceived social support (how much support an individual thinks or feels s/he is getting), actual/received social support (how many times an individual actually received some form of assistance, for example on a weekly basis), and/orsocial integration (the number of persons available to provide support).

The most important factors related to the individuals involved are: i) nature of the relationship(spouse, friend, clinician), ii) proximity and/or accessibility, iii) knowledge/experience with respect to the health problem or health behavior.

Of course there are also broader aspects to how social relationships influence health including social influence, social undermining, and social comparison.  This highlights an important point about social support, namely that it can also exert negative influences (aside from positive ones).  For example, long-term caregiving can be stressful and, eventually, taxing on the caregiver’s own health.  Similarly, a miss-match between the type of support desired/needed and the type received can be discouraging (or even damaging) to the person seeking support.

Strong levels of social support are linked with lower levels of stress, greater levels of happiness, and a longer life.  It is worthwhile to take a few moments to think about your current social network – in what ways is it is helpful (or harmful) to your health?  Next week we will provide a specific exercise you can do to increase the level of social support you receive from your own social network.

This entry was posted in MEMOTEXT Patient Adherence Team Blog. Bookmark the permalink.

Read More
10 Questions to Ask Before Determining Your Target Market


“We often overestimate the market size, and in many cases there may not be one at all,” says Robert Hisrich, director of the Walker Center for Global Entrepreneurship at the Thunderbird School of Global Management in Glendale, Ariz.

Here are 10 questions that can help you determine whether you have a target market and what it is:


Memotext uses Social Media to Curb Medical Non-Compliance

Medication non-compliance is commonly used in regard to a patient who does not take a prescribed medication or follow a prescribed course of treatment. It is costs 125,000 lives every year and losses of $100B across entire health care systems, employers and numerous health related industries tens of billions of dollars annually.

Non-compliance impacts all levels of health management, from treatment effectiveness to unnecessary hospitalizations. In addition, high expenses and lost revenues for payers, pharmaceutical companies, pharmacies and employers have a material effect on the health care system, payers, the insurance industry and the economy itself.

(Download to read more)
SmartMom Canada Memotext

Our Program

SmartMom Canada is a prenatal text messaging program, which texts important information to pregnant women about healthy pregnancy and birth timed to their stage of pregnancy. It is delivered free of charge.

Less than 30% of pregnant women in Canada go to prenatal education classes. Women often don’t know how to navigate the health care system or how to make informed decisions about their care during their pregnancy. SmartMom empowers women with timely information and alerts them to important issues, so they can make healthy choices for themselves and their babies.

These text messages inform women about options, recommend resources specific to their community, and encourage women to discuss important issues and options in pregnancy, childbirth and newborn care with their care provider (tests in pregnancy, cesarean section, breastfeeding, etc.). Check out our Facebook page during the campaign for more sneak peeks at the SmartMom text messages. (www.facebook.com/smartmomcanada)


Automated Med Reminders Boost Adherence

By: Brian Dolan | Jun 8, 2011

Amos Adler, President, Memotext

Glaucoma, the world’s second leading cause of blindness, has a number of effective therapies to help those afflicted. Despite these solutions, non-adherence rates for those treatments are reported to be between thirty- seven and fifty-nine percent. Luckily, mobile health professionals are working on ways to solve this issue. One such company, Memotext, has been developing adherence technologies and may have proof that its solution will improve those statistics.

Memotext and Microsoft’s recent study (funded by Microsoft and conducted by Johns Hopkins University) measured the efficacy of using the Memotext adherence solution combined with Microsoft’s personal health tracking platform HealthVault. Patients received some combination of text message reminders and IVR messages to remind them about their medication regimen.

PM360 Presents Novel Patient – Centric Strategies

Feature Articles by PM360 Staff on May 21st, 2013

Patient Centricity. You have probably heard that phrase a million times this year alone. After all, it is one of the biggest buzzwords of 2013. But there is a reason for that. Pharma needs to find a way to better reach and engage with patients— and this goes beyond ads that get them to ask their doctors about a specific brand. This is about better understanding patients and learning how pharma can better serve them. This is about improving patient adherence and outcomes.

The good news is that the industry gets that. We asked our readers for innovative patient-centric initiatives and strategies and our inboxes were flooded with responses. Of course, pharma is probably well aware that medical non- adherence costs the industry billions of dollars a year. (An estimated loss of $564 billion globally according to Capgemini Consulting.) But the industry also cares about giving patients a voice, providing them with tools that can help them stay on medication and creating an environment where they can connect with others like themselves.

MEMOTEXT(R) and BioGen Idec Canada Announce Ground-Breaking Partnership to Help MS Patients

TORONTO, ONTARIO — (MARKET WIRE) — 05/26/08 — Patients with Multiple Sclerosis (MS) who take the once-a-week prescription injection AVONEX® (interferon beta-1a) will now be the first in North America to benefit from a free and unique adherence solution program. BioGen Idec Canada, a subsidiary of Biogen Idec Inc., makers of AVONEX, and MEMOTEXT®, provider of personalized adherence solutions, have joined forces to help patients remember to take their medicine.

“It is no secret that one of the biggest challenges currently facing patients, their families and
the medical industry, is adherence. For some diseases, adherence rates are as low as 10-20%,” says Amos Adler, President of MEMOTEXT. “Studies show that long term adherence to treatment regimens, particularly when patients see signs of improvement, are abysmal. By providing education, live support and reminders to take medicines in a timely fashion this service will help improve quality of life over the long term.”



(Download to read more)
George Brown College Works With MEMOTEXT for Developing New Patient Adherence Program

Published on March 8, 2011 at 5:54 AM

George Brown College students work with MEMOTEXT Patient Adherence Solutions on the research and development of a new patient adherence program.

George Brown College is collaborating with MEMOTEXT, a patient adherence and medication compliance company, to develop an inference-based telephone/short message service (SMS) based communications program for an overseas health stakeholder-based research project.

As part of a Natural Sciences and Engineering Research Council of Canada (NSERC) grant, with support from George Brown College’s Office of Applied Research and Innovation, this collaboration allows MEMOTEXT to work hands on with multiple George Brown students in their respective fields. The program focuses on identifying patients’ psychological, historical and literacy levels as barriers to following a Type 2 Diabetes treatment regimen. MEMOTEXT is working with students from the Information Systems Business Analyst, and Health Information Management programs; each bringing their own unique level of expertise to the project.

(Download to read more)
10 Questions to Ask Before Determining Your Target Market

“We often overestimate the market size, and in many cases there may not be one at all,” says Robert Hisrich, director of the Walker Center for Global Entrepreneurship at the Thunderbird School of Global Management in Glendale, Ariz.

Here are 10 questions that can help you determine whether you have a target market and what it is:




(Download to read more)
A Spoonful of Sugar: Developing A Medication-Reminder App

By: John Moore

Sticking to a health regimen means remembering to take prescribed medications. But studies of medication adherence show that patients often fail to stay with the program. A prescription drug survey published by the National Community Pharmacists Association (NCPA) revealed that nearly 50 percent of consumers said they forgot to take a prescribed medication, while 24 percent said they took less than the recommended dosage.

Against this backdrop, MEMOTEXT, a company focused on medication- and treatment-compliance programs, offers a medication-adherence service that issues reminders to a patient’s mobile phone, tablet, PC or landline. The service is offered in more than 26 countries.

(Download to read more)
The Clinical and Economic Burden to Managed Care Organizations of Poor Medication Compliance in Cardiovascular Disease Risk and Diabetes, the role of MEMOTEXT

Summary: The clinical and economic burdens of patient non-compliance are well established, driven by broad chronic disease states such as cardiovascular diseases and diabetes. The economic impact of patient non-compliance is borne by managed care organizations through wasted pharmacy dispensing and the additional costs incurred from poor clinical outcomes. Adding to this cost is the lost opportunity to improve Medicare STAR ratings and PPACA identified quality measurements, several of which are specific to management of diabetes and hypertension, where patient compliance is a considerable challenge.

Patient non-compliance has multiple rationales. Health systems have tried different modalities to improve compliance, but historical efforts have resulted in limited success. Traditional compliance improvement modalities are either not individualized to the patient or are not economically feasible for large populations. Improving medication compliance through the use of technology integrated with behavioral health evidence has advanced to engage individual patients and personalized compliance communications are a solution. One technology is the MEMOTEXT Personalized Adherence Solutions, addressing the unmet need to individualize patient communication with proven results.


(Download to read more)
Drug Benefit News

January 24th, 2014

Aetna Tests the Weight-Loss Drug Waters With New Pilot and Pharma Collaboration

While many insurers and plan sponsors have been taking a “wait-and-see” approach to two relatively new anti-obesity medications, all eyes may now be on Aetna Inc. as it embarks on a clinically supported pilot to test the benefits of Vivus, Inc.’s Qsymia (phentermine and topiramate extended-release) and Eisai Inc.’s Belviq (lor- caserin HCl). The newly launched program, which is the first partnership of its kind for the drug makers, will evaluate the benefits of either agent “combined with lifestyle support.”

Qualifying members of self-insured plans that participate in the pilot will receive the drugs at a preferred brand copay and have access to mobile and other applications to help them stay on track with fitness, diet and other lifestyle goals. Doctors must prescribe the drugs, and Aetna will apply prior authorization criteria that are consis- tent with the drugs’ approved use by adult patients with an initial body mass index
of 30 or greater or overweight adults with a BMI of 27 or greater who also suffer from at least one weight-related comorbid condition (e.g., high blood pressure, high cho- lesterol, type 2 diabetes). Aetna will provide information about weight-loss options to all employees of plan sponsors who chose to participate in the pilot, and will conduct outreach to high-risk members about their covered weight-loss options through exist- ing wellness programs.

This is the first time Aetna is testing anti-obesity drugs as part of an overall weight- loss management program, which includes the use of CarePass, an application that allows members to “choose from curated applications in the areas of weight tracking, medication compliance, creating and following a physical activity plan and following a…

(Download to read more)
When Patients Don’t Take Medication – Everyone Gets Sick

October 22, 2012

The old adage, “an apple a day keeps the doctor away” has never been truer – so why aren’t patients eating them!

Studies show 50% of U.S. patients do not take their medicines as prescribed, resulting in over $300 billion annually in direct and indirect costs to the healthcare system and the economy. Non-compliance has been associated with as many as 125,000 deaths per year, 10% of older adult hospital admissions, 40% of admissions to nursing homes, 20% of cases of preventable adverse drug events, and an additional $2,000 a year/patient in medical costs for physician visits.

(Click PDF file to download)

Lorem Ipsum Link or Download
Stage 1 Attested, Philly Providers Hear Pitches for Niche IT Services

By Anthony Brino, Associate Editor

Now that most large, urban providers have adopted electronic health record (EHR) systems and are moving towards stage 2 meaningful use, IT vendors are offering more niche products for analytics, workflow and patient engagement.

At the Canada-U.S. eHealth Innovation Summit in Philadelphia, a dozen Canadian companies pitched a variety of clinical software modules, mobile apps and automation tools to CIOs and IT executives from local providers, several of which are in the midst of governance talks for the creation of a regional health information exchange.


(Download to read more)
America, the Land of Mobile Health Opportunity (video)

November 29, 2012 4:14 pm by Stephanie Baum | 0 Comments

The American mobile health app landscape is perceived as an open market for innovation. Yet the lack of any particular oversight or regulation specific to mobile health means there is a wide variety of apps on the market that swing from FDA approved medical devicesto apps that make unproven medical claims.

How One Healthcare Entrepreneur Created His Own Access

Like many healthcare entrepreneurs, Amos Adler of MEMOTEXT found it difficult to access the stakeholders who could help to make his patient adherenc company a success. The challenge, he said, is that access is dependent on how a startup can align with the business model of the stakeholders involved. “Can you get into their business model,” he said, “and can you get into the clinical workflow?”

To get around that, Adler and MEMOTEXT have found their own solution. “We’re in the midst of building out what we call ‘the alliance for adherence,'” he said. The patients and a common interest in patient adherence.

Here are other entrepreneurial insights from Adler:

(Download to read more)
Johns Hopkins Study Demonstrates 16% Increase in Patient Adherence Using MEMOTEXT

Amos Adler at Mobile Health 2011 presenting: What Really Works (CNW Group/MEMOTEXT Personalized Adherence Solutions)

TORONTO, June 8, 2011 /CNW/ – MEMOTEXT presented “The Impact of Automated Dosing Reminders on Medication Adherence Using HealthVault,” conducted by Johns Hopkins University and funded by the Microsoft HealthVault Be Well Fund at Mobile Health 2011: What Really Works conference at Stanford University May 4-5, 2011.

Preliminary results from the Automated Dosing Reminder Study (ADRS) were also presented at the March 2011 annual meeting of American Glaucoma Society.

Of the 428 participants analyzed thus far, the study showed an increase in adherence from 51 to 67% with daily glaucoma therapy using a MEMOTEXT adherence solution integrated with Microsoft HealthVault. A control group with no intervention showed no change in adherence. The study to be published this year demonstrates efficacy of MEMOTEXT solutions integrated with a personal health record.

“We are extremely pleased with the results of this adherence study.” says Amos Adler, president of MEMOTEXT. “Working with Dr. Boland and his team helped make this a success and we are proud of the impact this will have on the future of adherence and people living with glaucoma.”

(Download to read more)
Back to Top